Skip to main content

Headache in Autism Spectrum Disorders

  • Chapter
  • First Online:
Headache and Comorbidities in Childhood and Adolescence

Part of the book series: Headache ((HEAD))

Abstract

Gastrointestinal (GI) disorders are among the most common medical conditions associated with autism spectrum disorders (ASD). These conditions include chronic constipation or diarrhea and irritable and inflammatory bowel symptoms. The pain and discomfort caused by GI symptoms can worsen behavior and even trigger regression in children with ASD. Headache and related disorders may affect children with ASD as an additional problem to keep in mind when evaluating pain of uncertain origin in this vulnerable population. Headache and migraine are mainly diagnosed by clinical history with a thorough evaluation of primary and associated symptoms and the core communication difficulties of ASD may represent a serious flaw in doing it. Abdominal migraine is a subtype of migraine that deserves attention because it has similarities with gastrointestinal symptoms observed in children with ASD. In addition ASD and migraine are both comorbid with anxiety and a subgroup of individuals with ASD present with anxiety disorders further complicating the overall picture.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fulceri F, Morelli M, Santocchi E, Cena H, Del Bianco T, Narzisi A, Calderoni S, Muratori F. Gastrointestinal symptoms and behavioral problems in preschoolers with Autism Spectrum Disorder. Dig Liver Dis. 2016;48(3):248–54. doi:10.1016/j.dld.2015.11.026. Epub 2015 Dec 11.

    Article  PubMed  Google Scholar 

  2. de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418–24.

    Article  PubMed  Google Scholar 

  3. Ding HT, Taur Y, Walkup JT. Gut Microbiota and Autism: key concepts and findings. J Autism Dev Disord. 2017;47(2):480–9. doi:10.1007/s10803-016-2960-9.

    Article  PubMed  Google Scholar 

  4. Vuong HE, Hsiao EY. Emerging roles for the Gut Microbiome in Autism Spectrum Disorder. Biol Psychiatry. 2017;81(5):411–23. doi:10.1016/j.biopsych.2016.08.024.

    Article  PubMed  Google Scholar 

  5. Santocchi E, Guiducci L, Fulceri F, Billeci L, Buzzigoli E, Apicella F, et al. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters. BMC Psychiatry. 2016;16:183. doi:10.1186/s12888-016-0887-5.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dalton N, Chandler S, Turner C, Charman T, Pickles A, Loucas T, Simonoff E, Sullivan P, Baird G. Gut permeability in autism spectrum disorders. Autism Res. 2014;7(3):305–13.

    Article  PubMed  Google Scholar 

  7. Jackson J, Eaton W, Cascella N, Fasano A, Warfel D, Feldman S, et al. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res. 2012;140(1–3):262–3.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Fiorentino M, Sapone A, Senger S, Camhi SS, Kadzielski SM, Buie TM, et al. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7:49. eCollection 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ferguson BJ, Marler S, Altstein LL, Lee EB, Akers J, Sohl K, et al. Psychophysiological associations with gastrointestinal symptomatology in Autism Spectrum Disorder. Autism Res. 2017;10(2):276–88. doi:10.1002/aur.1646.

    Article  PubMed  Google Scholar 

  10. Casanova MF. The minicolumnopathy of autism: a link between migraine and gastrointestinal symptoms. Med Hypotheses. 2008;70:73–80. Epub 2007 Jun 14.

    Article  PubMed  Google Scholar 

  11. Casanova MF, van Kooten IA, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, et al. Minicolumnar abnormalities in autism. Acta Neuropathol (Berl). 2006;112(3):287–303.

    Article  Google Scholar 

  12. Venstra Wan der Weele J, Anderson G. In: Hollander E, Kolevzon A, Coyle JT, editors. Textbook of autism spectrum disorders. Arlington, VA: APA; 2011.

    Google Scholar 

  13. Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology. 2000;22:163–7.

    Article  CAS  PubMed  Google Scholar 

  14. Carrasco M, Volkmar FR, Bloch MH. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics. 2012;129(5):e1301–10.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Olmez A, Köse G, Turanli G. Cyclic vomiting with generalized epileptiform discharges responsive to topiramate therapy. Pediatr Neurol. 2006;35(5):348–51.

    Article  PubMed  Google Scholar 

  16. Winner P. Abdominal migraine. Semin Pediatr Neurol. 2016;23:11–3. doi:10.1016/j.spen.2015.09.001.

    Article  PubMed  Google Scholar 

  17. Canitano R. Epilepsy in Autism Spectrum Disorders. Eur Child Adolesc Psychiatry. 2007;16:61–6.

    Article  PubMed  Google Scholar 

  18. Sullivan JC, Miller LJ, Nielsen DM, Schoen SA. The presence of migraines and its association with sensory hyperreactivity and anxiety symptomatology in children with autism spectrum disorder. Autism. 2014;18(6):743–7. doi:10.1177/1362361313489377.

    Article  PubMed  Google Scholar 

  19. Green SA, Ben-Sasson A. Anxiety disorders and sensory over-responsivity in children with autism spectrum disorders: is there a causal relationship? J Autism Dev Disord. 2010;40(12):1495–504.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lane AE, Young RL, Baker AEZ, et al. Sensory processing subtypes in autism: association with adaptive behavior. J Autism Dev Disord. 2010;40:112–22.

    Article  PubMed  Google Scholar 

  21. Mazurek MO, Vasa RA, Kalb LG, Kanne SM, Rosenberg D, Keefer A, et al. Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol. 2013;41(1):165–76. doi:10.1007/s10802-012-9668-x.

    Article  PubMed  Google Scholar 

  22. Gargus JJ. Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Ann N Y Acad Sci. 2009;1151(1):133–56.

    Article  CAS  PubMed  Google Scholar 

  23. Williams K, Brignell A, Randall M, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013;8:CD004677.

    Google Scholar 

  24. de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, et al. Antibodies against food antigens in patients with autistic spectrum disorders. Biomed Res Int. 2013;2013:729349.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Severance EG, Dickerson FB, Halling M, Krivogorsky B, Haile L, Yang S, Stallings CR, Origoni AE, Bossis I, Xiao J, et al. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res. 2010;118(1–3):240–7.

    Article  PubMed  Google Scholar 

  26. Merison K, Jacobs H. Diagnosis and treatment of childhood migraine. Curr Treat Options Neurol. 2016;18(11):48.

    Article  PubMed  Google Scholar 

  27. Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017;376(2):115–24. doi:10.1056/NEJMoa1610384.

    Article  CAS  PubMed  Google Scholar 

  28. Green SA, Rudie JD, Colich NL, Wood JJ, Shirinyan D, Hernandez L, Tottenham N, Dapretto M, Bookheimer SY. Overreactive brain responses to sensory stimuli in youth with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2013;52(11):1158–72. doi:10.1016/j.jaac.2013.08.004.

    Article  PubMed  Google Scholar 

  29. Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. doi:10.1177/0333102413485658.

    Article  Google Scholar 

  30. Lagman-Bartolome AM, Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr Neurol Neurosci Rep. 2015;15(6):34. doi:10.1007/s11910-015-0551-3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Canitano M.D. .

Editor information

Editors and Affiliations

Appendices

Supplementary S1: Autism Spectrum Disorder - 5th ed.; DSM–5; American Psychiatric Association, 2013

14.1.1 Diagnostic Criteria

  1. A.

    Persistent deficits in social communication and social interaction across multiple contexts, as manifested by the following, currently or by history (examples are illustrative, not exhaustive, see text):

    1. 1.

      Deficits in social-emotional reciprocity, ranging, for example, from abnormal social approach and failure of normal back-and-forth conversation; to reduced sharing of interests, emotions, or affect; to failure to initiate or respond to social interactions.

    2. 2.

      Deficits in nonverbal communicative behaviors used for social interaction, ranging, for example, from poorly integrated verbal and nonverbal communication; to abnormalities in eye contact and body language or deficits in understanding and use of gestures; to a total lack of facial expressions and nonverbal communication.

    3. 3.

      Deficits in developing, maintaining, and understanding relationships, ranging, for example, from difficulties adjusting behavior to suit various social contexts; to difficulties in sharing imaginative play or in making friends; to absence of interest in peers.

      Specify current severity: Severity is based on social communication impairments and restricted repetitive patterns of behavior.

  2. B.

    Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following, currently or by history (examples are illustrative, not exhaustive; see text):

    1. 1.

      Stereotyped or repetitive motor movements, use of objects, or speech (e.g., simple motor stereotypies, lining up toys or flipping objects, echolalia, idiosyncratic phrases).

    2. 2.

      Insistence on sameness, inflexible adherence to routines, or ritualized patterns or verbal nonverbal behavior (e.g., extreme distress at small changes, difficulties with transitions, rigid thinking patterns, greeting rituals, need to take same route or eat food every day).

    3. 3.

      Highly restricted, fixated interests that are abnormal in intensity or focus (e.g, strong attachment to or preoccupation with unusual objects, excessively circumscribed or perseverative interest).

    4. 4.

      Hyper- or hyporeactivity to sensory input or unusual interests in sensory aspects of the environment (e.g., apparent indifference to pain/temperature, adverse response to specific sounds or textures, excessive smelling or touching of objects, visual fascination with lights or movement).

      Specify current severity:Severity is based on social communication impairments and restricted, repetitive patterns of behavior.

  3. C.

    Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities, or may be masked by learned strategies in later life).

  4. D.

    Symptoms cause clinically significant impairment in social, occupational, or other important areas of current functioning.

  5. E.

    These disturbances are not better explained by intellectual disability (intellectual developmental disorder) or global developmental delay. Intellectual disability and autism spectrum disorder frequently co-occur; to make comorbid diagnoses of autism spectrum disorder and intellectual disability, social communication should be below that expected for general developmental level.

Supplementary S2: Abdominal Migraine Modified by Winner P. [16]

14.1.1 Description

An idiopathic disorder seen mainly in children as recurrent attacks of moderate to severe midline abdominal pain, associated with vasomotor symptoms, nausea and vomiting, lasting 2–72 h, and with normality between episodes. Headache does not occur during these episodes.

14.1.2 Diagnostic Criteria

  1. A.

    At least five attacks of abdominal pain, fulfilling criteria B–D.

  2. B.

    Pain has at least two of the following three characteristics:

    1. 1.

      Midline location, periumbilical, or poorly localized

    2. 2.

      Dull or “just sore” quality

    3. 3.

      Moderate or severe intensity

  3. C.

    During attacks, at least two of the following:

    1. 1.

      Anorexia

    2. 2.

      Nausea

    3. 3.

      Vomiting

    4. 4.

      Pallor

  4. D.

    Attacks last 2–72 h when untreated or unsuccessfully treated.

  5. E.

    Complete freedom from symptoms between attacks.

  6. F.

    Not attributed to another disorder.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Canitano, R., Schröder, C.M. (2017). Headache in Autism Spectrum Disorders. In: Guidetti, V., Arruda, M., Ozge, A. (eds) Headache and Comorbidities in Childhood and Adolescence. Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-54726-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54726-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54725-1

  • Online ISBN: 978-3-319-54726-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics